Personalis Inc
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheet Details
Note 4. Balance Sheet Details
Inventory and other deferred costs consist of the following (in thousands):
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| Raw materials | $4,212 | $3,976 |
| Other deferred costs | 711 | 1,963 |
| Total inventory and other deferred costs | $4,923 | $5,939 |
Property and equipment. Depreciation and amortization expense for the three months ended March 31, 2025 and 2024 was $2.6 million and $2.8 million, respectively. Accumulated depreciation and amortization was $48.6 million and $46.0 million as of March 31, 2025 and December 31, 2024, respectively.
Restricted cash. The Company’s restricted cash is pledged as collateral for a standby letter of credit related to a property lease. The balance of restricted cash was $1.8 million as of March 31, 2025 and December 31, 2024, and is included in other long-term assets.
Accrued and other current liabilities consist of the following (in thousands):
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| Accrued compensation | $5,205 | $8,544 |
| Operating lease liabilities | 7,472 | 7,696 |
| Loans—current portion (Note 6) | 2,834 | 1,669 |
| Market Development Fees received from Tempus (Note 8) | 2,100 | 1,400 |
| Employee ESPP contributions | 740 | 301 |
| Other current liabilities | 1,663 | 2,019 |
| Total accrued and other current liabilities | $20,014 | $21,629 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.